Neuroinflammation, Neuroplasticity and the Future of Neurological Health: A Botanical Breakthrough

20 Jun 2026
Level 4 - Moore Room
Mental Health , Nutraceuticals
Altered neuroplasticity is now recognised as a central mechanism in both mood disorders and neurodegenerative disease — driven largely by chronic neuroinflammation and dysregulated microglial activity. This presentation explores how BDNF signalling and neurotrophic support link these conditions, and introduces the first RCT demonstrating that a novel bioavailable herbal combination achieved clinically meaningful reductions in depression scores in patients with inadequate antidepressant response. Cutting-edge neuroscience, translated into practical clinical strategies.
Speakers
Nathan Rose
Nathan Rose, Head of Education - Integria Healthcare | MediHerb | Eagle Clinical, Australia

Hosted by:

Balance Healthcare
Balance Healthcare
Stand: F5